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25(OH)D3 and Cardiovascular Risk
Factors in Female Nonhuman Primates
Matthew J. Jorgensen, Ph.D.,1 Lawrence L. Rudel, Ph.D.,2 Matthew Nudy,4,6 Jay R. Kaplan, Ph.D.,1
Thomas B. Clarkson, D.V.M., Nicholas M. Pajewski, Ph.D.,3 and Peter F. Schnatz, D.O.4,5,6,7
Abstract
Objective: To determine if interindividual differences in plasma concentrations of 25-hydroxyvitamin D3
(25(OH)D3) have pathophysiologic significance, we evaluated a cohort of female monkeys, seeking to identify
associations with clinically relevant cardiovascular risk factors, including age, abdominal obesity (waist cir-
cumference), and high-density lipoprotein cholesterol (HDL-C).
Methods: One hundred fifty-five female vervet monkeys (Chlorocebus aethiops sabaeus) aged 3–25 years consumed a
typical western diet for 7–8 weeks that provided a woman’s equivalent of approximately 1000 IU/day of vitamin
D3. Measurements of vitamin D3 and HDL-C concentrations, as well as waist circumference, were obtained.
Results: Among young monkeys (aged 3–5 years), compared to older monkeys (aged 16–25 years), the mean
plasma 25(OH)D3 concentrations were 82.3 – 3.2 ng/mL and 58.6 – 2.9 ng/mL ( p < 0.0001), respectively. Plasma
25(OH)D3 concentrations had a range of 19.6–142.0 ng/mL (mean – standard error [SE] 66.4 – 1.7 ng/mL).
25(OH)D3 concentrations were inversely associated with age ( p < 0.0001) and waist circumference ( p = 0.016) and
were positively correlated with HDL-C ( p = 0.01). However, when statistically controlling for age, none of these
relationships remained significant.
Conclusions: Higher plasma concentrations of 25(OH)D3 were associated with more favorable cardiovascular
risk factors, with inverse associations observed between 25(OH)D3 and abdominal obesity, HDL-C, and age.
These associations were no longer significant when controlling for age.
Introduction
It has beenwell established that vitaminD is an essentialnutrient associated with calcium absorption and bone
health. The link between vitamin D and extraskeletal benefits
has not been well established, and it is a frequently debated
topic. There is mounting evidence, however, associating low
vitamin D plasma concentrations or dietary intake with car-
diometabolic disorders, such as cardiovascular disease
(CVD)1,2 and type 2 diabetes.3,4 In addition, evidence has
linked vitamin D deficiency to risk factors for the develop-
ment of CVD,5 including age,6 obesity,7 hypercholester-
olemia,8,9 elevated triglycerides,10 and diabetes mellitus.11
There is also evidence that women have lower vitamin D
concentrations than men.12 Retrospective and cohort studies
have suggested an association between low plasma concen-
trations of vitamin D and an increased risk for coronary artery
atherosclerosis (CAA).13,14 Furthermore, the results of recent
studies indicate a deficiency in vitamin D may be a risk factor
for the metabolic syndrome, which is a major risk factor for
development of CAA.15–17 The National Cholesterol Educa-
tion Program’s Adult Treatment Panel III clinically defines the
metabolic syndrome as having three or more of the following
characteristics: abdominal obesity, elevated triglycerides, de-
creased high-density lipoprotein cholesterol (HDL-C), hy-
pertension, and elevated fasting glucose.18 The metabolic
syndrome is a highly prevalent condition among adults living
in the United States,19 making it an important health issue.
The Institute of Medicine’s (IOM) latest dietary reference
intakes (DRI) for vitamin D are 600 IU for individuals age £ 70
and 800 IU for those > age 70.20 Despite data suggesting a
cardiovascular benefit with adequate vitamin D concentra-
tions,1,21 the IOM committee reviewed vitamin D’s role in
extraskeletal health outcomes and made an assessment that
the current evidence only supports vitamin D’s beneficial role
in bone health. The report indicates there is a need for
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additional targeted research, however, and the committee has
not ruled out the possibility of suggesting higher intakes in
the future if the necessary evidence becomes available.22
When analyzing data from retrospective, observational,
and cohort studies, confounding variables may exist that can
be difficult to control. Retrospective populations, for example,
often have risk factors present in the population that can lead
to lower vitamin D levels and a greater risk of coronary heart
disease (CHD). For these reasons, studies that use nonbiased
or less-biased populations would be extremely beneficial and
important to further our knowledge about the link between
vitamin D and extraskeletal health outcomes.
Therefore, the objective of this study was to investigate
whether abdominal obesity, total plasma cholesterol (TPC),
HDL-C, and age are associated with plasma concentrations of
25-hydroxyvitamin D3 (25(OH)D3) in a cohort of female ver-
vet/African green monkeys. In this study, the use of a non-
human primate model allows for tight control of dietary
intake and environmental conditions, factors that frequently
lead to confounding variables in human studies.
Materials and Methods
Subjects
The subjects in this study were 155 nonpregnant, female
vervet/African green monkeys (Chlorocebus aethiops sabaeus)
from the Vervet Research Colony (VRC) of the Wake Forest
University Primate Center (WFPC). The VRC is a multigen-
erational, pedigreed, and genotyped colony that was founded
in 1975 with 57 animals imported from the islands of St. Kitts
and Nevis. The VRC has been a closed colony since the mid-
1980s, with no new animals imported since that time. In early
2008, the VRC was transferred from its original location in
California to the WFPC. At the time of the study, the colony
consisted of 486 animals in their second to eighth generation.
All animals were colony born and were of known age.
Housing
All subjects were housed in 16 social groups at the WFPC.
Each of the 16 housing pens consisted of a large outdoor area
(*1200 square feet) and a divided indoor area (300 square
feet). All penswere fittedwith elevated perches, platforms, and
climbing structures. Each of the 16 social groups contained one
or two adult males along with varying numbers of adult
females and immature offspring. In general, females remained
in their natal groups along with their mothers and sisters.
Males were removed at 4 years old to prevent inbreeding, and
adultmaleswere replaced every 3–5 years. Population sizewas
controlled by vasectomizing males and periodic culling. At the
time of the study, each of the 16 social groups housed between
11 and 49 animals (mean– standard deviation [SD]: 30.4– 11.7).
Diet
Before the study, all monkeys were fed a similar diet that
contained 6.6 IU/g of added vitamin D3, or the human
equivalent of 4000 IU/day. Then, as part of this study, all
monkeys were fed a challenge diet. This challenge diet was
formulated to mimic the typical American diet deriving 37%
of calories from fat, 18% from protein sources (mostly animal),
and 45% from carbohydrates and containing 0.18mg/Cal of
cholesterol. The diet contained 3.0 IU/g of added vitamin D3,
or the human equivalent of 1000 IU/day. A comparison of the
two diets is shown in Table 1. Throughout the study, animal
diets were supplemented with fresh fruits and vegetables
three times per week. All animals had ad libitum access to food
and water and opportunities to exercise.
Experimental procedures
Animals were sampled 7–8 weeks after they began con-
suming the challenge diet. One or two entire social groupswere
sampled per day, and the entire sampling period took place
over 2–3 weeks. Initiation of the challenge diet was staggered
so that a similar amount of time elapsed between the start of the
diet change and the collection of samples. On each sampling
day, animals were fasted overnight, captured, and anesthe-
tized with an intramuscular injection of 15mg/kg ketamine
HCl. Animals were weighed, morphometric measures were
taken, and bloodwas collected via femoral venipuncture using
6mL ethylenediaminetetraacetic acid (EDTA) Vacutainers and
3.5-mL serum-separating tubes (SST) tubes. The EDTA blood
samples were put on wet ice immediately after collection, and
the SST tubes were kept at ambient temperature. After sam-
pling was completed for the day, the samples were transferred
to the laboratory and centrifuged for 25 minutes at 1000g.
Aliquots of plasma were taken for lipid (600lL) and glycemic
(400lL) assays from the EDTA tubes, and 500lL aliquots of
serumwere taken from the SST tubes for vitamin D assays. All
samples were frozen at - 20C after initial processing and then
transferred to a - 80C freezer until assays were performed.
Morphometric measurements included body weight (BW),
waist circumference (WC), crown-rump length (CR), and
measurement of the suprasternal notch to the pubic sym-
physis distance (SNPS). WC was measured while animals
were in the supine position using a flexible tape measure that
was placed around the monkey’s abdomen at the level of the
umbilicus. The two length measurements were recorded us-
ing digital calipers while the animals were placed on their side
(CR) or supine (SNPS). Weight was measured in kilograms
(kg), and all other measurements were recorded in centime-
ters (cm). Separate body mass indices (BMI) were calculated
from each length measurement (kg/cm2). Interrater reli-
abilities were maintained at > 95% agreement.
Pregnancy status of adult females was determined by ul-
trasound on the date of sampling or if the animal gave birth
within 165 days of the sampling date (a time frame that would
indicate they were pregnant at the time of sampling). Ultra-
sound measurements were made by a trained veterinarian
Table 1. Diet Formulations for Standard
(Preliminary) Chow Diet and Challenge High-Fat Diet
Preliminary
dieta
Challenge
dietb
Fiber (crude) 5% 9%
Calories by protein 18% 18%
Calories by fat 13% 37%
Calories by carbohydrates 69% 45%
Metabolizable energy (kcal/g) 3.22 3.34
Vitamin D3 (IU/g) 6.6 3.0
Women’s equivalent (IU/day) 4000 1000
aChow (Purina LabDiet 5038).
bTypical American Diet (Purina LabDiet 5L0P).
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(SonoSite 180, Sono-Site Inc.) using previously established
protocols in this colony.23
Assays
Frozen serum samples (500lL) were assayed for 25(OH)D
(vitaminD2 andD3) usingHPLC/tandemmass spectrometry at
the Reading Hospital and Medical Center. Since 25(OH)D2 le-
vels were often below the level of detectability, only 25(OH)D3
data will be presented. Samples were protected from direct
sunlight throughout the process. Analyses used an Applied
Biosystems/MDS Sciex 3200 QTRAP liquid chromatography-
mass spectrometry/mass spectrometry (LC-MS/2) and a Shi-
madzu Prominence 20A LC System. Sample preparation was
based on a liquid-liquid extraction using acetonitrile to pre-
cipitate proteins, with reconstitution in methanol.
EDTA samples were assayed for the following variables:
total plasma cholesterol (TPC), triglycerides (TG), HDL-C, very
low-density lipoprotein cholesterol (VLDL-C), and low-density
lipoprotein cholesterol (LDL-C). All of the variables were
measured and reported in mg/dL. Lipoprotein cholesterol
distributions were determined using size separations of lipo-
protein classes via gel filtration chromatography.24 An aliquot
of plasma (containing about 15lg of cholesterol) diluted 1:1
with cold phosphate-buffered saline (PBS) was applied to a
Superose 6 column (GE Healthcare). The column was eluted
with 0.9% saline containing 0.01% EDTA and 0.01% sodium
azide at a flow rate of 0.4mL/min using a LaChromElite HPLC
system (Hitachi High Technologies), and the column eluate
was continuously mixed online with 0.125mL/min cholesterol
reagent (Cholesterol Liquid Reagent Set, Pointe Scientific, Inc.),
which was then passed through a 5-mL knitted reaction coil
maintained at 37C. Data readout is proportional to cholesterol
concentration in the eluate, and fractions containing VLDL,
LDL, and HDL were identified so that the percentage of cho-
lesterol in each could be determined. The cholesterol concen-
trations in each lipoprotein class were then calculated from a
direct measure of cholesterol concentration using an enzymatic
colorimetric assay in an aliquot of the starting plasma.
Plasma glucose (GLU, Sigma-Aldrich) and fructosamine
(FRUC, Roche Diagnostics) were assayed by enzymatic col-
orimetric methods. The interassay and intraassay coefficients
of variation (CV) % were < 5% for GLU and < 10% for FRUC.
Insulin (INS) was determined using ELISA (Mercodia), with
interassay and intraassay CV being < 10%.
Approvals
All procedures were approved by the Wake Forest In-
stitutional Animal Care and Use Committee (IACUC). Wake
Forest is an AAALAC accredited institution, and all animal
care procedures followed the NIH Guide.
Statistics
Unless otherwise noted, all results are reported as
mean– standard error of the mean (SE). All statistical analyses
were performed using SAS (version 9.1). Associations were
measuredusingPearson correlations, andmeandifferenceswere
tested using analysis of variance (ANOVA). F-test results with
degrees of freedom (df) are reported in addition to p values,with
p values<0.05 considered statistically significant. Associations
controlling for relatedness of individuals were performed using
Sequential Oligogenic Linkage Analysis Routines (SOLAR).25
Results
A total of 238 females were originally sampled, although
analyses were restricted to 155 nonpregnant females. Table 2
summarizes the descriptive statistics for the variables mea-
sured in this study. These females ranged in age from 3.5 to
24.7 years (10.4 – 0.4), and BW ranged from 3.3 to 7.7 kg
(5.1 – 0.1). WC ranged between 24.5 and 48.5 cm (33.3 – 0.3).
The distribution of 25(OH)D3 concentrations is shown in
Figure 1. The range of 25(OH)D3 concentrations was 19.6–
142.0 ng/mL, with a mean– SE of 66.4 – 1.7.
As shown in Figure 2, plasma 25(OH)D3 concentrations
were inversely associated with age (r= - 0.35, p<0.0001). As
show in Figure 3, among young monkeys (aged 3–5 years),
mean plasma 25(OH)D3 concentrations were 82.3–3.2ng/
mL vs. 58.6–2.9 in older monkeys (aged 16–25 years)
(F(3,151)=13.79, p<0.0001). Plasma 25(OH)D3 concentrations
were inversely associated with WC (r= -0.19, p=0.016). The
Table 2. Descriptive Statistics of All Variables
Variable Name (units) n Mean SE
25(OH)D3 25(OH)D3 (ng/mL) 155 66.4 1.7
Age Age (years) 155 10.4 0.4
BW Body weight (kg) 155 5.1 0.1
WC Waist circumference (cm) 153 33.3 0.3
CR Crown-rump length (cm) 153 44.2 0.1
SNPS Suprasternal notch to pubic symphysis distance (cm) 153 29.5 0.1
BMI (CR) Body mass index w/CR (kg/cm2) 153 25.9 0.3
BMI (SNPS) BMI w/SNPS (kg/cm2) 153 58.4 0.7
TPC Total plasma cholesterol (mg/dL) 155 207.6 3.4
HDLC High-density lipoprotein cholesterol (mg/dL) 155 109.0 2.3
TPC:HDLC TPC/HDL-C ratio 155 2.0 0.0
VLDLC Very low density lipoprotein cholesterol (mg/dL) 155 2.0 0.1
LDLC Low-density lipoprotein cholesterol (mg/dL) 155 96.6 2.4
VLDLC +LDLC VLDL-C +LDL-C 155 98.6 2.4
TG Triglycerides (mg/dL) 155 36.9 1.5
GLU Glucose (mg/dL) 155 65.5 1.5
FRUC Fructosamine (umol/L) 155 154.2 2.5
INS Insulin (mU/L) 155 14.1 1.4
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females in the lowest quartile (Q1) of 25(OH)D3 concentrations
hadWCof 34.2–0.6 cmvs. the highest quartile (Q4)withWC of
31.5–0.7 cm (F(3,149)=32.48, p<0.05) (Q2=33.4–0.6 cm,
Q3=34.0–0.6 cm). Plasma 25(OH)D3 concentrations were
positively correlated with HDL-C (r=0.20, p=0.01) (Figure 4).
Thus, the lowest quartile of 25(OH)D3 had mean HDL-C con-
centrations that were 14.9mg/dL less than the highest quartile
(F(3,151)=1.88, p=0.14) (Q1=102.8–4.3mg/dL, Q2=106.7–
4.1mg/dL, Q3=214.5–7.5mg/dL, Q4=117.7–4.6mg/dL).
Table 3 shows the correlations between the different car-
diometabolic risk factors (morphometric, lipid, and glycemic)
and 25(OH)D3 concentrations, age, and 25(OH)D3 concen-
trations with age as a covariate. Whereas a number of vari-
ables were correlated with 25(OH)D3 concentrations, many of
these variables were also correlated with age. When control-
ling for age statistically, only the positive relationship be-
tween 25(OH)D3 and total cholesterol remained significant
(r= 0.19, p= 0.0204).
Because all the animals in this study were part of one large
pedigree, the assumptions of independence of observationswere
violated. Separate analyses of the correlations were performed
with SOLAR, taking into account the relatedness of individuals.
None of the correlations were significantly altered by the inclu-
sion of relatedness as a factor. It should also be noted that calcium
concentrations from 152 of the 155 animals, measured as part of
annual veterinary health screening, were positively (though not
significantly) correlated with 25(OH)D3 concentrations.
Discussion
Using these nonhuman primates as surrogates for aging
women, we have shown that lower concentrations of
FIG. 1. Histogram of vitamin D3 concentrations.
FIG. 2. Scatterplot of 25(OH)D3 concentrations (ng/mL), by age in years (r= - 0.35, p< 0.0001).
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25(OH)D3 are significantly associated with increasing age,
higher abdominal obesity, and decreased HDL-C and TPC.
Conversely, higher plasma concentrations of 25(OH)D3 are
associated with cardiometabolic parameters that support a
potential mechanism for cardioprotection. Our findings are
consistent with studies that have found significant associa-
tions between vitamin D and abdominal obesity,7 age,6 and
HDL-C8,9 in human populations. When statistically con-
trolling for age, however, only the relationship between
25(OH)D3 and TPC remained significant. Although the direct
association between 25(OH)D3 and TPC may appear to be
unexpected, we believe our study model provides a logical
explanation. More specifically, TPC and HDL-C tend to cov-
ary in vervets.26 It is likely, therefore, that the TPC effect is
being driven by HDL-C in this species and, hence, presents a
slight variation from the human model and one that should
not divert our focus from the other significant and relevant
findings. Previously, we have shown a significant association
between low plasma concentrations of 25(OH)D3 and lower
HDL-C in a cohort of female cynomolgus monkeys (Macaca
fascicularis),9 an effect that is consistent with the positive cor-
relation between 25(OH)D3 and HDL-C in the present report.
Numerous reports have shown that vitamin D is associated
inversely with age6,27 and obesity.1,7,28 However, less well
understood is whether the association is the result of old age
and obesity, leading to lifestyles that cause lower plasma
concentrations of vitamin D. For example, persons of older
age can reside in assisted living facilities and, therefore, have
less sun exposure and less plasma vitamin D concentrations.
In addition, obese individuals may have less exposure to
FIG. 3. Mean + standard error (SE) of 25(OH)D3 concentrations by age category.
FIG. 4. Scatterplot of 25(OH)D3 concentrations (ng/dL) by high-density lipoprotein cholesterol (HDL-C) concentrations
(mg/dL) (r= 0.20, p = 0.01).
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ultraviolet light because of decreased outdoor physical ac-
tivity. It has been suggested that because of the fat-soluble
nature of vitamin D, the major storage form of vitamin D,
25(OH)D3, can be sequestered in adipose tissue, causing de-
creased plasma concentrations of vitamin D in obese indi-
viduals.29
Vitamin D deficiency is a widespread health concern. The
Third National Health and Nutrition Examination Survey re-
ports vitamin D deficiency may be present in 25%–57% of
American adults.30 Less well understood, however, is whether
the large individual differences in plasma concentrations of
vitaminDhave any extraskeletal pathophysiologic significance.
As vitamin D supplementation is becoming a popular method
used by clinicians to raise vitamin D concentrations, it was very
interesting to see 25(OH)D3 concentrations ranging from 19.6 to
142.0ng/mL in this cohort. Recall, despite this wide variation,
that each monkey was fed a diet with identical doses of oral
vitaminD (1000 IU/day) alongwith similar housing conditions
and sun exposure. This finding has been observed in human
populations as well, where studies suggest between 18% and
53% of individuals will respond to vitamin D supplementa-
tion.31,32 The outdoor housing and supplementation of the
diet also help explain why very few of the animals in this study
showed 25(OH)D3 concentrations < 40ng/dL, levels that
would be considered low in a typical human population.
Future studies on this topic would be beneficial. A pro-
spective analysis that examines the effects of vitamin D
supplementation on abdominal obesity, TPC, HDL-C, and the
metabolic syndrome would be clinically beneficial. In addi-
tion, a study that seeks to explain the mechanism for the link
among vitamin D, TPC, and HDL-C would further our
knowledge on vitamin D and its role in CVD. Further inves-
tigations explaining why such large differences in vitamin D
concentrations are observed after supplementing with
1000 IU/day and what causes an individual not to respond to
supplementation would have major clinical significance. Fi-
nally, a randomized controlled trial using vitamin D and de-
signed to test for CVD as the primary outcome would be
beneficial, as these types of analyses are nearly nonexistent.
Conclusions
The clinical relevance of our findings is important. This
report suggests an explanation for why individuals with low
plasma concentrations of vitamin D may be at an increased
risk for CHD. In our sample, female vervet/African green
monkeys with lower plasma 25(OH)D3 concentrations had
significantly lower HDL-C levels and greater abdominal
obesity, both of which are well-recognized risk factors for the
development of CHD. In addition, we observed a significant
inverse relationship between age and plasma concentration of
25(OH)D3. It should be noted that when age was used as a
covariate, many of the associations between 25(OH)D3 and
other CVD risk factors were no longer significant. The study
was done in such a way that the entire cohort had the same
housing conditions and was fed the same diet, thus reducing
variability in sun exposure and vitamin D intake. This ap-
proach allowed for finer control of variables that confound
similar studies of human subjects.
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Table 3. Correlations Between Cardiovascular Risk Factors and a) 25(OH)D3, b) Age,
c) 25(OH)D3 with Age as Covariate (n = 153–155)
Pearson correlation
with 25(OH)D3
Pearson correlation
with age
Partial correlation with 25(OH)D3
(age as covariate)
Variable r p r p r p
BW - 0.13 0.10 0.27 <0.001 - 0.04 0.60
WC 20.19 0.02 0.39 <0.0001 - 0.07 0.41
CR 0.06 0.45 0.05 0.56 0.08 0.31
SNPS 0.04 0.61 0.10 0.21 0.08 0.31
BMI (CR) 20.17 0.04 0.28 <0.001 - 0.08 0.35
BMI (SNPS) - 0.16 0.05 0.22 <0.01 - 0.09 0.28
TPC 0.22 0.01 - 0.14 0.08 0.19 0.02
HDLC 0.20 0.01 20.20 0.01 0.14 0.07
TPC:HDLC 0.01 0.88 0.13 0.11 0.06 0.45
VLDLC 0.02 0.80 0.16 0.05 0.08 0.31
LDLC 0.12 0.14 - 0.01 0.87 0.12 0.13
VLDLC +LDLC 0.12 0.14 - 0.01 0.94 0.12 0.13
TG 0.03 0.74 0.26 0.001 0.13 0.10
GLU - 0.04 0.60 0.20 0.02 0.03 0.73
FRUC - 0.03 0.74 0.10 0.21 0.01 0.91
INS 0.07 0.41 0.04 0.62 0.09 0.29
Bold face type indicates significant findings.
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